MYCN and liver cancer: AurA binds to N-Myc and c-Myc and is thought to slow the formation of ubiquitin chains by the SCFFbxw7 complex, resulting in enhanced stability of N-Myc in neuroblastoma and neuroendocrine prostate cancer and of c-Myc in liver cancer [20–22].